Andrea Christopher

Executive Director, Corporate Communications & Investor Relations

Andrea Christopher joined Aurinia in 2023 and oversees corporate communications and investor relations. She is responsible for developing corporate communications strategies that support company reputation and brand growth, strategic investor communications, and employee communications.

Mrs. Christopher has over 20 years of healthcare and pharmaceutical communications experience, with expertise in healthcare and scientific communications, public relations and marketing, employee engagement, and crisis and issues management.

From 2007 to 2023, Mrs. Christopher held successive communications roles at UCB, including a global role leading strategic external and internal communications for UCB’s 800-person immunology business unit. In her time at UCB, Mrs. Christopher worked across neurology and immunology teams, leading product launch communications campaigns, disease awareness initiatives, early and late-stage scientific communications, media relations efforts, executive visibility and thought leadership initiatives, and launched Advantage Hers, UCB’s first celebrity campaign for women of childbearing age living with chronic autoimmune diseases.

Prior to joining UCB, Mrs. Christopher was an Account Supervisor in the healthcare practice at Ogilvy Public Relations Worldwide. Mrs. Christopher began her career in the healthcare practice at Porter Novelli, a global public relations agency. 

Mrs. Christopher earned her B.A. from Syracuse University, where she majored in Public Affairs in Syracuse’s Maxwell School of Citizenship & Public Affairs.